Article

Radiogenomic Prediction of MGMT Promoter Methylation Status in Glioblastoma Using Multi-Modal MRI and EfficientNet

2024-10-08

Abstract excerpt

MGMT promotor hypermethylation is the most important biomarker for predicting temozolomide sensitivity in aggressive glioblastoma (GBM), a disease with a poor prognosis. An MGMT status prediction without biopsy is mandatory for tailored therapy because methylated MGMT patients have better prognosis. To this end, this paper proposes the radiogenomic model for predicting the status of MGMT Promoter methylation in gl...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 21bff605-034d-5939-879c-006d1d7adf3b
DOI: 10.20944/preprints202410.0583.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Radiogenomic Prediction of MGMT Promoter Methylation Status in Glioblastoma Using Multi-Modal MRI and EfficientNetDOI 10.20944/preprints202410.0583.v1Read

GLIA-Deep: Glioblastoma Image Analysis Using Deep Learning Convolutional Neural Networks to Accurately Classify Gene Methylation and Predict Drug EffectivenessSemantic proximity Read

Brain tumor Radiogenomic Classification and Prediction of Glioblastoma Status using MRI Scans with Deep Learning AlgorithmsSemantic proximity Read

MGMT promoter methylation status prediction using MRI scans? An extensive experimental evaluation of deep learning modelsSemantic proximity Read

Competent Radiogenomics Features for the Prediction of glioma MutationsSemantic proximity Read

GlioVision: A Multi-Modal MRI Framework for Non-Invasive Glioma Molecular Biomarkers PredictionSemantic proximity Read

Predicting MGMT Methylation in Glioblastoma for Informed Clinical Decisions: An AI-Driven Approach in Resource-Limited SettingsSemantic proximity Read

XGBoost Improves Classification of MGMT Promoter Methylation Status in IDH1 Wildtype GlioblastomaSemantic proximity Read

Radiogenomic profiling of global DNA methylation associated with molecular phenotypes and immune features in glioma.Semantic proximity Read

Predicting glioblastoma molecular subtypes and prognosis with a multimodal model integrating convolutional neural network, radiomics, and semantics.Semantic proximity Read

Automated machine learning to predict the co-occurrence of isocitrate dehydrogenase mutations and O6 -methylguanine-DNA methyltransferase promoter methylation in patients with gliomas.Semantic proximity Read

Improving Glioblastoma Prognosis with MRI based Machine LearningSemantic proximity Read

Radiomics signature: A potential biomarker for the prediction of MGMT promoter methylation in glioblastomaSemantic proximity Read